General News

MHRA portal for reporting ADRs to swine flu vaccines

The MHRA have issued a letter to health care professionals, seeking to clarify arrangements for reporting ADRs (adverse drug reactions) to Tamiflu, Relenza and future swine flu H1N1 vaccines.

A new Swine Flu ADR portal has been launched (www.mhra.gov.uk/swineflu) which has been designed to make the process of ADR reporting as efficient as possible. The portal will remain active for the length of the swine flu pandemic.

How to report a suspected adverse reaction

Please report suspected ADRs to Swine flu antivirals via the Swine Flu ADR Portal at www.mhra.gov.uk/swineflu

Please remember to include the following important information in your report:

the patient’s age
the indication (prophylaxis or treatment)
information on any underlying risk factors for influenza complications or the ADR; or state if there are no known risk factors
any other information about the patient or additional clinical details which will help in the assessment of the case

The full communication to health professionals can be seen on the MHRA website.

Posted 7 July 2009

< Back